Answer
Yes. Its licence includes moderate to severe vasomotor symptoms caused by adjuvant endocrine therapy for breast cancer.
Sources for this answer
- Lynkuet 60 mg soft capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.